Skip to main content

The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma.

Belenky A, Smith A, Zhang B, Lin S, Despres N, Wu AH, Bluestein BI

Publication: Clin Chim Acta (2004) • Vol 340 • Page 163-72PMID: 14734208View on PubMed

Purpose

This paper investigated the storage time- and temperature-dependent degradation of B-type natriuretic peptide (BNP) in plasma, as well as in BNP-spiked plasma and human serum albumin (HSA) specimens. Eight protease inhibitors were also examined for their potential attenuation of BNP degradation.

Conclusion

All protease inhibitors tested slowed down the proteolytic degradation of BNP. In the absence of protease inhibitor, 10% of the exogenously added BNP was detected after storage at 4 degrees C for 40 h and no BNP was detectable by 6 d. Storage of plasma specimens at room temperature resulted in more degradation of endogenous BNP compared to storage at 2-8 degrees C, but degradation could be blocked with PPACKII. HSA was found to cause proteolysis of 85% of added BNP within 3 d, but this too was effectively blocked for at least 4 weeks by the addition of DFP or PPACKII. In conclusion, PPACKII and DFP can effectively block degradation of endogenous or exogenous BNP in plasma and HSA.

Studies (3)

Purpose

This study examined the stability of BNP, assessed in plasma specimens spiked with synthetic BNP, after refrigerated storage as well as the preservation capacity of 8 different protease inhibitors.

Summary of Findings

All protease inhibitors tested slowed down the proteolytic degradation of BNP. In the absence of inhibitors, 10% of the exogenously added BNP was detected after storage at 4 degrees C for 40 h and no BNP was detectable by 6 d. The addition of 50 ug/ml of antipain, leupeptin, PPACKI, PPACKII or DFP completely prevented the proteolysis of BNP for up to 6 d at 2-8 degrees C. Doses as low as 0.62 ug/ml allowed for 40% recovery after 6 days with antipain and leupeptin and 80% after 6 d with PPACKII. The generic serine protease inhibitors AEBSF and benzamidine allowed for 80% recovery of BNP at 6 d. Aprotinin was much less effective at preserving the BNP and only 20% of BNP was recoverable after 6 d. In conclusion antipain, leupeptin, PPACKI, PPACKII or DFP were highly effective while AEBSF and benzamidine were slightly less effective at blocking proteolysis of BNP.
  • Biospecimens

    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    PeptideClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    StorageStorage duration
    0
    1 day
    2 days
    6 days
    6 h
    StorageStorage temperature
    2-8 degrees C
    Analyte Extraction and PurificationProtease inhibitor
    4-(2-aminoethyl)-benzenesulfonylfluoride (AEBSF)
    Antipain
    Benzenecarboximidamide (benzamidine)
    Diisopropylfluorophosphate (DFP)
    Leupeptin
    No protease inhibitor added
    PPACKI
    PPACKII